Skip to main content
Caplight Logo









MARAbio

MARAbio

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://marabio.com

Last Round

Series A

Oct 8, 2024

Total Funding Raised

$19M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MARAbio operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was a Series A round in October 2024.

MARAbio is a biotechnology company that develops a blood test to identify the risk of developing Maternal Autoantibody Related Autism (MARA).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MARAbio Comparables

Compare MARAbio with similar companies based on industry and business-model similarity.

MARAbio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LinusBio
80%
Quadrant Biosciences Inc.
77%
BioROSA Technologies
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MARAbio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 8, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

MARAbio Investors

Notable investors and investment history

MARAbio investors
InvestorRounds
MAK Capital OneSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 128% MoM, reaching 4K.

  • Jul 25, 2026

    Monthly visitors grew 53% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

MARAbio Filings

Explore SEC and related filing metadata, where available.

MARAbio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MARAbio's valuation, stock price, and market status.

Is MARAbio a public or private company?

MARAbio is a private company.

What is the current stock price of MARAbio?

MARAbio is a private company, so its shares have no public market price. Caplight tracks MARAbio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MARAbio worth (valuation)?

Valuation information for MARAbio is not publicly available.

Can I buy MARAbio stock?

MARAbio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MARAbio's last funding round?

MARAbio's most recent funding round was Series A on October 8, 2024.

Who are the main investors in MARAbio?

Key investors in MARAbio include MAK Capital One.

Will MARAbio IPO soon?

No public IPO plans have been announced for MARAbio.

How can I track MARAbio secondary market activity?

Caplight tracks bids, offers, and trades in MARAbio's shares on secondary markets.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range12
Year Founded2016
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?